Nektar Therapeutics NKTR
$73.02
-3.82%
at last close
Financials (TTM)
- Revenue
- $55.63 million
- Net Income
- $-158,098,000
- Net Margin
- -284.18%
- Return on Equity
- -27.44%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 4.46
- Price / Sales
- 46.17
Over the trailing twelve months, Nektar Therapeutics generated revenue of $55.63 million and net income of $-158,098,000, a net margin of -284.18%.
At the last closing price of $73.02, NKTR trades at 46.17 times sales, with a market capitalization of $2.57 billion.
Key Stats
- Last Close
- $73.02
- Market Cap
- $2.57 billion
- 52-Week Range
- $21.02 – $109.00
- Average Volume
- 734K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.